title: Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1).
abstract: BACKGROUND
  As it is unknown whether complete asthma remission or progression of asthma is associated with airway inflammation and remodeling, we assessed these characteristics in bronchial biopsies of relevant subsets of asthma patients.
  
  
  METHODS
  Sputum and bronchial biopsies were obtained from asthma patients in remission (PC(20) histamine> 32 mg/ml, PC(20) AMP> 320 mg/ml) and from those with either a slow FEV(1) decline (< 30 ml/year) or fast decline (> 30 ml/year). Inflammatory cells and mediators were determined in sputum, inflammatory cells and aspects of airway remodeling in bronchial biopsies.
  
  
  RESULTS
  Asthmatics in remission and asthma patients with a slow FEV(1) decline had a similar extent of airway inflammation and remodeling in sputum and bronchial biopsies. Asthma patients with a fast FEV(1) decline had high sputum eosinophil numbers. Moreover, FEV(1) decline (ml/year) correlated with sputum eosinophil numbers (Rs=0.51, p=0.003) and ECP levels (Rs=0.57, p=0.001). Airway remodeling, i.e. basement membrane thickness, correlated with sputum eosinophils (Rs=0.69, p<0.001), sputum ECP (Rs=0.46, p=0.018) and airway wall eosinophil numbers (Rs=0.49, p=0.002).
  
  
  CONCLUSIONS
  Asthma, even when in remission, is accompanied by airway inflammation and remodeling. Data suggest that eosinophils are important in a subset of asthma patients by association to accelerated FEV(1) decline and change of basement membrane thickness.
authors.affiliation: Dept. of Pathology, University of Groningen, Groningen, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Broekema
authors.forename: F
authors.initials: F
authors.lastname: Volbeda
authors.forename: W
authors.initials: W
authors.lastname: Timens
authors.forename: A
authors.initials: A
authors.lastname: Dijkstra
authors.forename: N A
authors.initials: NA
authors.lastname: Lee
authors.forename: J J
authors.initials: JJ
authors.lastname: Lee
authors.forename: M E
authors.initials: ME
authors.lastname: Lodewijk
authors.forename: D S
authors.initials: DS
authors.lastname: Postma
authors.forename: M N
authors.initials: MN
authors.lastname: Hylkema
authors.forename: N H T
authors.initials: NH
authors.lastname: ten Hacken
mesh_terms: D000328:Adult; D000368:Aged; D056151:Airway Remodeling / Q000502:physiology*; D001249:Asthma / Q000473:pathology* / Q000503:physiopathology; D001999:Bronchoscopy; D018450:Disease Progression; D004802:Eosinophilia / Q000473:pathology* / Q000503:physiopathology; D004804:Eosinophils / Q000473:pathology; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous; D013183:Sputum / Q000166:cytology / Q000378:metabolism
chemical_list: D018836:Inflammation Mediators